EP1136470A4 - Procede de preparation de derive piperazine - Google Patents
Procede de preparation de derive piperazineInfo
- Publication number
- EP1136470A4 EP1136470A4 EP00962874A EP00962874A EP1136470A4 EP 1136470 A4 EP1136470 A4 EP 1136470A4 EP 00962874 A EP00962874 A EP 00962874A EP 00962874 A EP00962874 A EP 00962874A EP 1136470 A4 EP1136470 A4 EP 1136470A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- piperazine derivative
- preparation
- phenylpiperazine
- mirtazapine
- cyanopyridine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C209/00—Preparation of compounds containing amino groups bound to a carbon skeleton
- C07C209/68—Preparation of compounds containing amino groups bound to a carbon skeleton from amines, by reactions not involving amino groups, e.g. reduction of unsaturated amines, aromatisation, or substitution of the carbon skeleton
- C07C209/74—Preparation of compounds containing amino groups bound to a carbon skeleton from amines, by reactions not involving amino groups, e.g. reduction of unsaturated amines, aromatisation, or substitution of the carbon skeleton by halogenation, hydrohalogenation, dehalogenation, or dehydrohalogenation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C213/04—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reaction of ammonia or amines with olefin oxides or halohydrins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C215/22—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated
- C07C215/28—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
- C07C215/30—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings containing hydroxy groups and carbon atoms of six-membered aromatic rings bound to the same carbon atom of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/84—Nitriles
- C07D213/85—Nitriles in position 3
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP28037899 | 1999-09-30 | ||
JP28037899 | 1999-09-30 | ||
WOPCT/JP00/05432 | 2000-08-14 | ||
PCT/JP2000/005432 WO2001025185A1 (fr) | 1999-09-30 | 2000-08-14 | Procede de production de derive de piperazine |
PCT/JP2000/006650 WO2001023345A1 (fr) | 1999-09-30 | 2000-09-27 | Procede de preparation de derive piperazine |
Publications (3)
Publication Number | Publication Date |
---|---|
EP1136470A1 EP1136470A1 (fr) | 2001-09-26 |
EP1136470A4 true EP1136470A4 (fr) | 2004-09-22 |
EP1136470B1 EP1136470B1 (fr) | 2007-08-22 |
Family
ID=17624194
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP00962874A Expired - Lifetime EP1136470B1 (fr) | 1999-09-30 | 2000-09-27 | Procede de preparation de derive piperazine |
Country Status (8)
Country | Link |
---|---|
US (1) | US6495685B1 (fr) |
EP (1) | EP1136470B1 (fr) |
JP (3) | JP4330836B2 (fr) |
AT (1) | ATE370736T1 (fr) |
AU (2) | AU6476300A (fr) |
CA (1) | CA2351528C (fr) |
DE (1) | DE60036076D1 (fr) |
WO (2) | WO2001025185A1 (fr) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UA83666C2 (ru) | 2003-07-10 | 2008-08-11 | Н.В. Органон | Способ получения энантиомерно чистого миртазапина |
US7838029B1 (en) * | 2003-07-31 | 2010-11-23 | Watson Laboratories, Inc. | Mirtazapine solid dosage forms |
EP1783125A4 (fr) * | 2004-08-24 | 2008-06-18 | Sumitomo Chemical Co | Methode de production de 2-(4-methyl-2-phenylpiperazine-1-yl)-3-cyanopyridine |
WO2006113425A1 (fr) * | 2005-04-14 | 2006-10-26 | Teva Pharmaceutical Industries Ltd. | Processus de preparation de fumarate de quetiapine |
CN102126982A (zh) * | 2005-09-26 | 2011-07-20 | 住友化学株式会社 | 光学活性的哌嗪化合物的制造方法 |
JP5080050B2 (ja) * | 2005-09-26 | 2012-11-21 | 住友化学株式会社 | 光学活性なピペラジン化合物の製造方法 |
WO2007055423A1 (fr) * | 2005-11-14 | 2007-05-18 | Sumitomo Chemical Company, Limited | Procede de fabrication de 2-(4-methyl-2-phenylpiperazin- 1-yl)pyridine-3-methanol |
CN101679431B (zh) | 2007-04-11 | 2013-08-14 | Msd欧斯股份有限公司 | 制备四环苯并氮杂卓的对映异构体的方法 |
CN101440067B (zh) * | 2007-11-21 | 2010-08-25 | 上海津力化工有限公司 | 一种药物中间体1-甲基-3-苯基哌嗪的制备方法 |
JP6392344B2 (ja) * | 2013-07-25 | 2018-09-19 | ドン−ア エスティ カンパニー リミテッド | ベンズアミド誘導体の製造方法、その製造に使用される新規な中間体及び該中間体の製造方法 |
CN103509000A (zh) * | 2013-10-21 | 2014-01-15 | 山东鲁药制药有限公司 | 一种药物中间体1-(3-氰甲基吡啶基-2)-4-甲基-2-苯基哌嗪的合成方法 |
CN109988148A (zh) * | 2018-01-02 | 2019-07-09 | 北京哈三联科技有限责任公司 | 1-(3-氰基吡啶-2)-2-苯基-4-甲基哌嗪草酸盐的制备方法 |
CN114878727B (zh) * | 2022-05-06 | 2023-07-25 | 合肥高尔生命健康科学研究院有限公司 | 一种测定烟草中噁霉灵残留物的方法 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1181322A (en) | 1967-06-29 | 1970-02-11 | Chugai Pharmaceutical Co Ltd | Piperazine Derivatives and processes for preparing the same |
JPS4417388B1 (fr) * | 1967-06-29 | 1969-07-31 | ||
NL179906C (nl) | 1974-02-09 | 1986-12-01 | Akzo Nv | Werkwijze voor het bereiden van 1,2,3,4,10,14b-hexahydrodibenzo(c,f)pyrazino (1,2-a)azepine derivaten. |
US4217452A (en) * | 1974-02-09 | 1980-08-12 | Akzona Incorporated | Synthesis for the preparation of tetracyclic compounds |
NL189199C (nl) * | 1975-04-05 | 1993-02-01 | Akzo Nv | Werkwijze ter bereiding van farmaceutische preparaten met werking op het centraal zenuwstelsel op basis van benz(aryl)azepinederivaten, de verkregen gevormde farmaceutische preparaten, alsmede werkwijze ter bereiding van de toe te passen benz(aryl)azepinederivaten. |
JPS5315520A (en) | 1976-07-28 | 1978-02-13 | Chino Kiki Seisakushiyo Kk | Transformer protector |
JPS5942678A (ja) | 1982-09-03 | 1984-03-09 | Akai Electric Co Ltd | 磁気記録再生装置における編集方法 |
FR2573075B1 (fr) * | 1984-09-14 | 1987-03-20 | Innothera Lab Sa | Nouvelles (pyridyl-2)-1 piperazines, leur procede de preparation et leur application en therapeutique |
US4772705A (en) | 1985-07-25 | 1988-09-20 | Pennwalt Corporation | Processes for the preparation of trans 1,3,4,6,7,11b-hexahydro-7-aryl-2H-pyrazinol[2,1-a]isoquinolines |
US6339156B1 (en) | 1999-04-19 | 2002-01-15 | Teva Pharmaceuticals Industries, Ltd. | Synthesis of piperazine ring |
-
2000
- 2000-08-14 AU AU64763/00A patent/AU6476300A/en not_active Abandoned
- 2000-08-14 WO PCT/JP2000/005432 patent/WO2001025185A1/fr active Application Filing
- 2000-09-27 DE DE60036076T patent/DE60036076D1/de not_active Expired - Fee Related
- 2000-09-27 JP JP2001526500A patent/JP4330836B2/ja not_active Expired - Fee Related
- 2000-09-27 CA CA002351528A patent/CA2351528C/fr not_active Expired - Fee Related
- 2000-09-27 AU AU74455/00A patent/AU751629B2/en not_active Ceased
- 2000-09-27 AT AT00962874T patent/ATE370736T1/de not_active IP Right Cessation
- 2000-09-27 EP EP00962874A patent/EP1136470B1/fr not_active Expired - Lifetime
- 2000-09-27 WO PCT/JP2000/006650 patent/WO2001023345A1/fr active IP Right Grant
- 2000-10-27 US US09/697,140 patent/US6495685B1/en not_active Expired - Fee Related
-
2008
- 2008-10-09 JP JP2008262502A patent/JP5161023B2/ja not_active Expired - Fee Related
-
2012
- 2012-10-18 JP JP2012231010A patent/JP5656952B2/ja not_active Expired - Fee Related
Non-Patent Citations (1)
Title |
---|
No further relevant documents disclosed * |
Also Published As
Publication number | Publication date |
---|---|
US6495685B1 (en) | 2002-12-17 |
CA2351528A1 (fr) | 2001-04-05 |
CA2351528C (fr) | 2005-11-29 |
AU6476300A (en) | 2001-05-10 |
AU751629B2 (en) | 2002-08-22 |
JP2013040196A (ja) | 2013-02-28 |
DE60036076D1 (de) | 2007-10-04 |
JP5656952B2 (ja) | 2015-01-21 |
JP2009167166A (ja) | 2009-07-30 |
WO2001023345A1 (fr) | 2001-04-05 |
JP4330836B2 (ja) | 2009-09-16 |
EP1136470A1 (fr) | 2001-09-26 |
ATE370736T1 (de) | 2007-09-15 |
WO2001025185A1 (fr) | 2001-04-12 |
JP5161023B2 (ja) | 2013-03-13 |
EP1136470B1 (fr) | 2007-08-22 |
AU7445500A (en) | 2001-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1136470A4 (fr) | Procede de preparation de derive piperazine | |
PL1781683T3 (pl) | Sposób wytwarzania 17-winylo-trifluorometanosulfonianów jako związków pośrednich | |
EP1690861A3 (fr) | Procédé pour la préparation de duloxetine et produits intermédiaires utiles dans le procédé | |
HUS1600015I1 (hu) | Eljárás 2-alkil-3-aminotiofén-származékok elõállítására és új 3-aminotiofén-származékok | |
DE60333733D1 (en) | Clohexancarbonsäurederivats | |
SI1125924T1 (sl) | Intermediat za sintezo amlodipina, postopek za pripravo in ustrezna uporaba | |
IL150120A0 (en) | Process for the preparation of a pyridinemethanol compound | |
WO2007039117A3 (fr) | Procede pour preparer des derives de sartan, et produits intermediaires pouvant etre utilises pour ce procede | |
WO2003004459A3 (fr) | Fabrication de composes nitrile | |
DK1489080T3 (da) | Fremgangsmåde til frembringelse af cilostazol | |
IL133814A0 (en) | Process for the preparation of 1-aryl-3-cyclopropyl-1, 3-propanediones | |
EA199900458A2 (ru) | Способ и промежуточные продукты для получения пиридин-2,3-дикарбоксилатов | |
PL336053A1 (en) | Novel derivatives of amino pyridine, methods of obtaining them, methods obtaining (4-(2-(2-(6-aminopyridin-3-yl(-2(r)-hydroxyethylamino)ethoxy)phenyl) acetic acid, its novel polymorphous form and pharmaceutic agent | |
FI102747B (fi) | Menetelmä 4-asyylitioatsetidin-2-onijohdannaisten valmistamiseksi | |
CA2384925A1 (fr) | Procede de preparation de derives de l'oxazole | |
AU6520498A (en) | Process for producing piperidinecarboxylic acid amides | |
RO117371B1 (ro) | Procedeu pentru obţinerea clorhidratului de (e) -n-metil-n-(1-naftilmetil)-3-fenil-2-propen-1-amină | |
MXPA04000949A (es) | Proceso para la preparacion de derivados de 3-espiroæciclohexam-1,3æ-æ3h!indolin-2æ-ona!. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20010529 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
AX | Request for extension of the european patent |
Free format text: AL;LT;LV;MK;RO;SI |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20040805 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: 7C 07C 209/74 B Ipc: 7C 07D 401/04 B Ipc: 7A 61K 31/517 A Ipc: 7C 07D 213/85 B Ipc: 7C 07D 241/04 B |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: SUMITOMO CHEMICAL COMPANY, LIMITED |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: SUMITOMO CHEMICAL COMPANY, LIMITED |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
REF | Corresponds to: |
Ref document number: 60036076 Country of ref document: DE Date of ref document: 20071004 Kind code of ref document: P |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20071203 Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20070822 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20070822 |
|
NLV1 | Nl: lapsed or annulled due to failure to fulfill the requirements of art. 29p and 29m of the patents act | ||
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CH Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20070822 Ref country code: LI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20070822 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20070822 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20070822 |
|
EN | Fr: translation not filed | ||
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20071123 Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20070822 Ref country code: MC Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20070930 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20080122 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20071122 |
|
26N | No opposition filed |
Effective date: 20080526 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20080401 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20070927 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20070930 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20070822 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20070927 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20070930 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20120926 Year of fee payment: 13 |
|
GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 20130927 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20130927 |